Nifty Below 22,600 at Midday: Can Markets Hold Before Expiry?
Based on market data as of 13:05 IST on 29 September 2026.
At a glance
Sensex is down 600+ points and Nifty50 is trading below 22,600 at six-month lows, putting 2026 on track for its worst annual performance since 2011.
Nifty Bank has crashed nearly 1,800 points in just two days, the rupee has breached 96 per US dollar, and India VIX (the volatility index, a measure of expected market swings) has spiked to multi-month highs.
Pharma is the lone bright spot, rising 1% after the US waived tariffs on specialty drugs imported from India.
The setup
At 1:05 PM IST, Indian equity markets are showing no meaningful recovery from the morning selloff. The morning trend has not reversed — if anything, it has deepened. The Sensex is down over 600 points and the Nifty50 has slipped below 22,600, breaching multiple support levels. What makes today especially tense is the calendar: this is the monthly options expiry day, and the Closing Auction Session (CAS) — a special 15-minute window at the end of the trading day where final prices are determined — coincides with that expiry. That combination means the last 30 minutes of today's session could be the most volatile of the entire day. With 2.5 hours left, the question is not whether markets are bearish — they clearly are — but whether a floor forms before the bell or the selling accelerates.
Top 5 sentiment drivers
Risk factors. A rare convergence of domestic and global risks is driving today's selloff — strongly bearish at -0.72. Iran nuclear talks have stalled after Trump rejected sanctions relief, the US-Canada trade war has escalated with a $1 billion (approximately ₹8,300 crore) import ban, India VIX has spiked to multi-month highs, the RBI (Reserve Bank of India) has drained $20 billion in liquidity through forex operations, and Fed (US Federal Reserve) rate hike expectations are resurfacing — all at once.
Banking sector outlook. Nifty Bank is strongly bearish at -0.72, having lost nearly 1,800 points in just two trading sessions to fall below 54,000 for the first time in four months. HDFC Bank shares have slipped below ₹719.05 ahead of its Q2 results due October 17, while the RBI's $20 billion liquidity drain is tightening systemic credit conditions and raising concerns about banks' NIM (Net Interest Margin — the difference between what banks earn on loans and pay on deposits).
Market volatility outlook. India VIX has spiked to multi-month highs, signalling that options traders expect sharp swings — strongly bearish at -0.70. Today's monthly options expiry creates a "gamma squeeze" risk (a situation where market makers are forced to buy or sell large quantities rapidly to hedge their positions), and the CAS coinciding with expiry makes the final 30 minutes particularly unpredictable. Market expert Vinit Bolinjkar of Ventura Securities has specifically warned investors against chasing momentum in this environment.
Currency and commodity impact. The rupee has hit a two-month low of 96.1450 per US dollar, breaching the psychologically important 96 level — strongly bearish at -0.68. Crude oil is edging higher, which directly worsens India's CAD (Current Account Deficit — the gap between what India earns and spends in foreign trade). Gold has fallen ₹4,300 per 10 grams and silver has dropped ₹8,800 per kilogram in two days, both weighed down by rising US yields and Fed rate hike fears.
Geopolitical risk premium. Iran nuclear negotiations are at a critical juncture — Trump has rejected sanctions relief while Iran awaits a US response — keeping crude oil elevated and adding a risk premium to global markets, scoring moderately bearish at -0.60. The US-Canada trade war is escalating simultaneously, with a $1 billion import ban signalling broader trade fragmentation that could eventually affect India's own export relationships with the US.
Sectors in focus
Banking. Strongly bearish at -0.72 — Nifty Bank's two-day, 1,800-point crash below 54,000 reflects a toxic mix of RBI liquidity tightening, rupee weakness raising asset quality concerns, and rising US yields squeezing NIM expectations, with HDFC Bank's upcoming Q2 results on October 17 adding an overhang.
IT. Mildly bearish at -0.45 — JM Financial has flagged a likely soft Q2 earnings season for IT majors including TCS and Infosys, citing demand weakness, while global tech sentiment is cautious ahead of Micron's results; an Indian IT vendor being jailed in Singapore for a data breach adds a reputational cloud over the sector.
Auto and Manufacturing. Mildly bullish at +0.15 — festive season demand delivered an 81.8% year-on-year (YoY) uptick in early September 2026 volumes, and the bullet train project's 100-metre steel bridge installation in Maharashtra signals steady manufacturing activity; however, the rupee at 96/USD is raising costs on imported components, and analysts are questioning whether valuations have run ahead of earnings.
Pharma. Moderately bullish at +0.55 — Nifty Pharma is the clear outperformer today, up 1% against a falling market, after the US granted zero-duty status on specialty drugs imported from India and 19 other countries; Motilal Oswal's ₹910 target price for Aster DM Healthcare, based on a projected 25% EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) CAGR (Compound Annual Growth Rate) through FY28, adds to the sector's positive narrative.
Global and macro backdrop
Global cues are offering little comfort. APAC (Asia-Pacific) stocks were mostly subdued through the morning, and while European equity futures point to a flat-to-slightly-positive open, that is not enough to offset domestic headwinds. US Treasury yields remain elevated, which strengthens the dollar and pulls FII (Foreign Institutional Investor) money out of emerging markets like India. The rupee at 96.1450/USD is a direct reflection of these outflows. RBI's $20 billion forex intervention — while aimed at stabilising the rupee — has drained surplus liquidity from the banking system, acting as a de facto tightening measure. On the domestic institutional side, DII (Domestic Institutional Investor) buying may be providing some floor, but the IPO (Initial Public Offering) pipeline swelling to nearly ₹4 lakh crore (₹4,00,000 crore) is raising concerns about a secondary market liquidity squeeze — money flowing into new listings is money not available to support existing stocks. A block deal in Honasa Consumer worth ₹643 crore by Peak XV (formerly Sequoia India) is also a reminder that institutional sellers are active.
Risks to watch
Expiry-driven volatility: The monthly options expiry combined with today's CAS window means the last 30 minutes — roughly 3:00 PM to 3:30 PM IST — could see sharp, sudden moves in either direction.
Rupee slippage: If the rupee weakens further past 96.50/USD, it could trigger a fresh round of FII selling and amplify the equity selloff.
Crude oil spike: Any escalation in Iran nuclear tensions before market close could push crude higher, worsening India's fiscal math and sentiment simultaneously.
Banking contagion: If Nifty Bank breaks below a fresh support level in afternoon trade, it could drag the broader Nifty50 down with it, given banking's heavy weight in the index.
What this means for the rest of today's session
The next 2.5 hours are unlikely to be calm. The bearish trend that opened the morning has held through lunch, and the structural drivers — rupee weakness, RBI liquidity tightening, Fed rate hike fears, and geopolitical risk — are not going to resolve before 3:30 PM. The real wildcard is the options expiry and CAS combination: markets could see a sharp move in either direction in the final 30 minutes as traders square off positions. Pharma remains the only sector offering relative shelter. For investors already holding positions, today's session is primarily about watching how the market closes — the closing level will set the tone for tomorrow's opening on September 30.
How to read this
What this sentiment is measuring. We score 16 distinct dimensions of market sentiment, covering broad market direction, key sectors (banking, IT, auto and manufacturing, pharma), global cues, FII / DII flows, currency and commodities, regulatory stance across India and major foreign jurisdictions, and risk indicators. Each dimension is given a score from −1 (strongly bearish) to +1 (strongly bullish), paired with a 0 to 1 confidence weight that reflects how much supporting evidence the model found. The overall score shown in the dial is a confidence-weighted blend of all dimensions on the same −1 to +1 scale.
What data is used. The analysis draws on Indian and global financial news, regulatory and policy feeds from India as well as major foreign jurisdictions, and market news from global exchanges. News items are filtered for freshness and relevance before being scored, so the picture reflects what the market is reading and reacting to right now.
Limitations. This article is not investment advice and not a recommendation to buy, sell, or hold any security. The output is best treated as a structured attribute set — useful as one input among many when building your own prediction models or sense-checking your own view, not as a forecast on its own.
Comments